drugset / Trial / NCT03633604

Expanded Access IND Administration of HBOC-201 in Patients With Severe Acute Anemia

NCT03633604

Expanded access No longer available Michael Boisen HbO2 Therapeutics LLC · collab

Summary

HBOC-201 provides an oxygen treatment bridge and can be used to eliminate, delay, or reduce the need for red blood cell transfusions in anemic patients This is an expanded access IND protocol, and will provide treatment with HBOC-201 to severely anemic adults for whom blood is not an option

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject HBOC-201 Protein / enzyme biologic Intravenous

Indications